Search research articles
Contact Us
Filters
Showing results (21-30 of 415) with videos related to
Page
of 42
Sort By:
Metabolites
|
January 20, 2022
The Interaction between the Gut Microbiome and Bile Acids in Cardiometabolic Diseases
Cengiz Callender, Ilias Attaye, Max Nieuwdorp
Expert Opinion on Therapeutic Targets
|
May 23, 2020
The interaction between microbiome and host central nervous system: the gut-brain axis as a potential new therapeutic target in the treatment of obesity and cardiometabolic disease
Madelief Wijdeveld, Max Nieuwdorp, Richard IJzerman
Cell Metabolism
|
September 2, 2014
Microbial modulation of insulin sensitivity
Muhammad Tanweer Khan, Max Nieuwdorp, Fredrik Bäckhed
Current Diabetes Reports
|
June 29, 2019
Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes?
Judith Aron-Wisnewsky, Karine Clément, Max Nieuwdorp
Diabetologia
|
December 26, 2016
Emerging role of intestinal microbiota and microbial metabolites in metabolic control
Hilde Herrema, Richard G IJzerman, Max Nieuwdorp
Handbook of Experimental Pharmacology
|
March 19, 2020
Microbiome and Cardiovascular Disease
Hilde Herrema, Max Nieuwdorp, Albert K Groen
Nature Reviews. Gastroenterology & Hepatology
|
June 3, 2024
Endogenous ethanol production in health and disease
Abraham S Meijnikman, Max Nieuwdorp, Bernd Schnabl
Frontiers in Genetics
|
December 17, 2021
A Genetic Map of the Modern Urban Society of Amsterdam
Bart Ferwerda, Abdel Abdellaoui, Max Nieuwdorp, et al.
Current Opinion in Lipidology
|
September 28, 2016
Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk
Annefleur M Koopen, Albert K Groen, Max Nieuwdorp
Metabolites
|
February 25, 2025
From Microbes to Metabolites: Advances in Gut Microbiome Research in Type 1 Diabetes
Lente Blok, Nordin Hanssen, Max Nieuwdorp, et al.
Page
of 42
Search research articles
Search
Showing results (21-30 of 415) with videos related to
Sort By:
Page
of 42
Metabolites
|
January 20, 2022
The Interaction between the Gut Microbiome and Bile Acids in Cardiometabolic Diseases
Cengiz Callender, Ilias Attaye, Max Nieuwdorp
Expert Opinion on Therapeutic Targets
|
May 23, 2020
The interaction between microbiome and host central nervous system: the gut-brain axis as a potential new therapeutic target in the treatment of obesity and cardiometabolic disease
Madelief Wijdeveld, Max Nieuwdorp, Richard IJzerman
Cell Metabolism
|
September 2, 2014
Microbial modulation of insulin sensitivity
Muhammad Tanweer Khan, Max Nieuwdorp, Fredrik Bäckhed
Current Diabetes Reports
|
June 29, 2019
Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes?
Judith Aron-Wisnewsky, Karine Clément, Max Nieuwdorp
Diabetologia
|
December 26, 2016
Emerging role of intestinal microbiota and microbial metabolites in metabolic control
Hilde Herrema, Richard G IJzerman, Max Nieuwdorp
Handbook of Experimental Pharmacology
|
March 19, 2020
Microbiome and Cardiovascular Disease
Hilde Herrema, Max Nieuwdorp, Albert K Groen
Nature Reviews. Gastroenterology & Hepatology
|
June 3, 2024
Endogenous ethanol production in health and disease
Abraham S Meijnikman, Max Nieuwdorp, Bernd Schnabl
Frontiers in Genetics
|
December 17, 2021
A Genetic Map of the Modern Urban Society of Amsterdam
Bart Ferwerda, Abdel Abdellaoui, Max Nieuwdorp, et al.
Current Opinion in Lipidology
|
September 28, 2016
Human microbiome as therapeutic intervention target to reduce cardiovascular disease risk
Annefleur M Koopen, Albert K Groen, Max Nieuwdorp
Metabolites
|
February 25, 2025
From Microbes to Metabolites: Advances in Gut Microbiome Research in Type 1 Diabetes
Lente Blok, Nordin Hanssen, Max Nieuwdorp, et al.
Page
of 42